On Wednesday, June 10, 2026, leading experts from the Democratic Republic of the Congo (DRC), World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC), and the Global Virus Network (GVN) will convene a critical media briefing to discuss the ongoing Ebola outbreak caused by the Bundibugyo strain. This international panel of virologists, epidemiologists, and public health officials will provide an in-depth analysis of the scientific and operational challenges confronting the global health community in responding to this pressing crisis.
The outbreak in the DRC represents a particularly formidable challenge due to the nature of the Bundibugyo Ebola virus, a less common but highly pathogenic species within the Ebolavirus genus. Unlike the more widely studied Zaire strain, which has been the subject of extensive vaccine and therapeutic development, the Bundibugyo strain presents unique diagnostic hurdles. Rapid, sensitive, and specific diagnostics are crucial for outbreak containment, yet current tools still struggle to reliably detect this variant in field conditions, impeding timely patient isolation and contact tracing efforts.
Professor Jean-Jacques Muyembe Tamfum, a pioneering figure in Ebola virus research and the 2026 Virchow Prize recipient, will offer invaluable insights from his decades of experience. As the director of the Institut National de Recherche Biomédicale in the DRC and co-inventor of the monoclonal antibody treatment mAb114 (Ebanga), Professor Muyembe brings a historical and practical perspective on viral hemorrhagic fever outbreak management. His leadership in the first recognized Ebola outbreak in 1976 and subsequent therapeutic innovations underscore the evolving complexity of confronting emerging viral threats.
Adding a global health policy dimension, Professor Maria Van Kerkhove, acting director of WHO’s Epidemic and Pandemic Department, will discuss how international coordination is pivotal in mobilizing resources and expertise. She will elaborate on WHO’s strategic approach to epidemic preparedness and real-time response, including vaccine deployment, community engagement, and health system strengthening in the DRC and neighboring regions.
Representing the Africa CDC’s frontline emergency response, Professor Yap Boum II will provide a detailed account of operational measures undertaken in the DRC amid compounded public health pressures. His commentary will highlight the necessity of a “One Team, One Plan” framework to harmonize efforts across affected borders without resorting to disruptive closures that could exacerbate regional vulnerabilities.
Professor Salim S. Abdool Karim, a renowned global health expert affiliated with CAPRISA and Africa CDC, will address the critical gaps in diagnostic technologies underscored by the current outbreak. He emphasizes that the absence of robust, rapid tests capable of discriminating the Bundibugyo strain leads to reactive instead of proactive epidemic control. His analysis stresses that improving diagnostic platforms must be a global priority to bolster infection prevention and control protocols effectively.
On the virology front, Professor Robert F. Garry Jr., from Tulane University, will elucidate the molecular and immunological underpinnings of Bundibugyo virus pathogenicity. His expertise in viral genomics and the virus-host interaction informs ongoing research aimed at developing broadly protective vaccines and therapeutics that can accommodate viral diversity and mutations, thus preparing for future spillover events.
Professor Sten H. Vermund, Chief Medical Officer of GVN and Dean at the University of South Florida College of Public Health, will synthesize the discussion by contextualizing the outbreak within the broader framework of pandemic preparedness and global health security. He will underscore the importance of sustained investment in virus surveillance networks capable of early detection and rapid response to reduce the risk of widespread transmission beyond endemic regions.
Moderated by Professor Christian Bréchot, former president of Institut Pasteur and Vice Chair of GVN’s Board, the briefing aims to arm journalists with authoritative scientific information to counter misinformation and fear. By integrating voices from research, frontline response, and international oversight, the event seeks to foster nuanced understanding of the outbreak’s dynamics, the limitations of current countermeasures, and the urgency of collaborative action.
The Bundibugyo Ebola crisis not only challenges the scientific community to innovate swiftly but also tests the resilience of health infrastructures in vulnerable regions. It signals the complexity of emerging infectious diseases at the interface of human, animal, and environmental health, exemplifying the One Health concept that underpins contemporary epidemic strategy.
As the panelists engage in a live Q&A, the conversation will extend to the potential role of next-generation diagnostics, the pipeline for vaccine candidates specific to Bundibugyo virus, and how integrated regional surveillance can preempt future outbreaks. These discussions spotlight the intersection of science and policy in crafting adaptive responses that can be scaled globally.
This media briefing emphasizes that defeating Ebola outbreaks, especially those involving less-characterized strains like Bundibugyo, demands a synthesis of cutting-edge science, pragmatic field operations, and cohesive international collaboration. The lessons learned here are critical not only for Ebola but also for broader viral hemorrhagic fever preparedness worldwide.
The Global Virus Network invites media representatives to register and join this pivotal dialogue, aiming to enhance public comprehension of one of the most enduring and complex viral threats facing humanity today.
Subject of Research: Epidemiology, Diagnostics, Vaccines, and Therapeutics related to the Bundibugyo Ebola Virus Outbreak
Article Title: Global Experts Convene to Address the Bundibugyo Ebola Outbreak: Challenges and Advances in Viral Hemorrhagic Fever Control
News Publication Date: June 10, 2026
Web References:
Global Virus Network: https://gvn.org
Institut National de Recherche Biomédicale: https://inrb.net/index.php
World Health Organization: https://www.who.int
Africa CDC: https://africacdc.org
CAPRISA: https://www.caprisa.org
Tulane University Microbiology: https://medicine.tulane.edu/departments/faculty/robert-garry-jr-phd
Keywords: Bundibugyo Ebola, Ebola virus disease, rapid diagnostics, outbreak response, viral hemorrhagic fever, pandemic preparedness, Global Virus Network, Africa CDC, World Health Organization, vaccine development, mAb114 (Ebanga), viral genomics.
Tags: Africa CDC Ebola responseBundibugyo Ebola virus challengesBundibugyo strain epidemiologycontact tracing in Ebola outbreaksEbola outbreak Democratic Republic of the CongoEbola patient isolation methodsEbola virus diagnostic difficultiesEbola virus vaccine developmentGlobal Virus Network media briefinginternational public health collaboration EbolaJean-Jacques Muyembe Tamfum Ebola researchWHO Ebola containment strategies
